DAVID G JOHNSON to Biomarkers, Tumor
This is a "connection" page, showing publications DAVID G JOHNSON has written about Biomarkers, Tumor.
Connection Strength
0.072
-
Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol. 2013 Aug; 162(3):348-59.
Score: 0.030
-
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res. 2010 Mar 15; 16(6):1856-64.
Score: 0.024
-
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients. Leukemia. 2020 11; 34(11):3091-3096.
Score: 0.012
-
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood. 2010 Jul 15; 116(2):250-3.
Score: 0.006